February 2, 202400:06:43

Molly Gamble, Vice President of Editorial at Becker’s Healthcare

In this episode, Molly Gamble, Vice President of Editorial at Becker’s Healthcare discusses announced healthcare executive moves & exits in 2024, Intermountain ending their precision medicine program and healthcare hopeful 23andMe's valuation down 98%.

Loading transcript...